Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Maruho Co., Ltd.
Age
12–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Non-pregnant female subjects ≥ 12 years of age with facial acne vulgaris
Subjects with an Investigator's Global Assessment (IGA) of Inflammatory Lesions of Acne Vulgaris of Moderate (3) or Severe (4) at Baseline.
Subjects with ≥ 30 facial inflammatory lesions
You may not be if
Subjects with \< 10 or \> 75 facial non-inflammatory lesions
Subjects with \> 3 facial nodular or cystic lesions at Baseline
Clareo Health | A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
